Oral valganciclovir <i>versus</i> intravenous ganciclovir as preemptive treatment for cytomegalovirus infection after living donor liver transplantation: A randomized trial-Reference-Cited by-同舟云学术

Oral valganciclovir versus intravenous ganciclovir as preemptive treatment for cytomegalovirus infection after living donor liver transplantation: A randomized trial

Published:2011 Issue:5 Volume:5 Page:217-222
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Togashi Junichi¹,Sugawara Yasuhiko¹,Hashimoto Masao²,Tamura Sumihito¹,Kaneko Junichi¹,Aoki Taku¹,Hasegawa Kiyoshi¹,Kokudo Norihiro¹

Affiliation:

1. Artificial Organ and Transplantation Surgery Division, Department of Surgery, The University of Tokyo

2. Division of Viral Immunology, Centers for AIDS Research, Kumamoto University

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health(social science)

Reference19 articles.

1. 1. Kanj SS, Sharara AI, Clavien PA, Hamilton JD. Cytomegalovirus infection following liver transplantation: Review of the literature. Clin Infect Dis. 1996; 22:537-549.

2. 2. Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev. 1997; 10:86-124.

3. 3. Stratta RJ, Shaeffer MS, Markin RS, et al. Cytomegalovirus infection and disease after liver transplantation. An overview. Dig Dis Sci. 1992; 37:673-688.

4. 4. Paya CV. Prevention of cytomegalovirus disease in recipients of solid-organ transplants. Clin Infect Dis. 2001; 32:596-603.

5. 5. Limaye AP, Bakthavatsalam R, Kim HW, Randolph SE, Halldorson JB, Healey PJ, Kuhr CS, Levy AE, Perkins JD, Reyes JD, Boeckh M. Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis. Transplantation. 2006; 81:1645-1652.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic review;BMJ Open;2020-01

2. Risk-guided strategy to prevent cytomegalovirus associated complications after liver transplantation;Future Virology;2018-07

3. Drugs for Herpesvirus Infections;Infectious Diseases;2017

4. Treatment of alpha and beta herpesvirus infections in solid organ transplant recipients;Expert Review of Anti-infective Therapy;2016-12-12

5. CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS;Russian Journal of Transplantology and Artificial Organs;2016-04-16